Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit
- PMID: 28687573
- PMCID: PMC6317845
- DOI: 10.6004/jnccn.2017.0127
Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit
Comment in
-
To the Editor: Predictive Markers and Precision Medicine.J Natl Compr Canc Netw. 2017 Oct;15(10):1186. doi: 10.6004/jnccn.2017.7040. J Natl Compr Canc Netw. 2017. PMID: 28982743 No abstract available.
References
-
- Le Tourneau C, Delord JP, Goncalves A, et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol 2015;16:1324–1334. - PubMed
-
- Schwaederle M, Zhao M, Lee JJ, et al. Association of biomarker-based treatment strategies with response rates and progression-free survival in refractory malignant neoplasms: a meta-analysis. JAMA Oncol 2016;2:1452–1459. - PubMed
-
- Wheler JJ, Janku F, Naing A, et al. Cancer therapy directed by comprehensive genomic profiling: a single center study. Cancer Res 2016;76:3690–3701. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
